neural progenitor cell

Cell therapyexperimental

Clinical trial activity

3 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2013 (NCT02854579)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • NeuronsTissue restoration

    Neurons tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • neural progenitor cell

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04284293Phase 1Mar 31, 2020California Institute for Regenerative Medicine (CIRM), Cedars-Sinai Medical Center, Retina-Vitreous Associates Medical Group
NCT02177578Phase 2May 1, 2014Johns Hopkins University
NCT02854579N/AJan 1, 2013Bethune International Peace Hospital, Government of China, People's Liberation Army of China, Shangluo Central Hospital, United States Navy, University of South China
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Bethune International Peace HospitalAcademic/Hospital1012013
California Institute for Regenerative Medicine (CIRM)Academic/Hospital1012020
Cedars-Sinai Medical CenterAcademic/Hospital1112020
Government of ChinaGovernment1112013
Johns Hopkins UniversityAcademic/Hospital1112014
People's Liberation Army of ChinaGovernment1012013
Retina-Vitreous Associates Medical GroupAcademic/Hospital1012020
Shangluo Central HospitalAcademic/Hospital1012013
United States NavyGovernment1012013
University of South ChinaAcademic/Hospital1012013
10 organizations
Page 1 / 1